Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China · Delayed Price · Currency is CNY 25.00
-0.45 (-1.77%)
At close: Feb 13, 2026
SHA:600645 Market Cap
SHA:600645 has a market cap or net worth of 11.4 billion as of February 13, 2026. Its market cap has increased by 27.62% in one year.
Market Cap
11.40B
Enterprise Value
9.86B
Revenue
1.47B
Ranking
n/a
PE Ratio
149.86
Stock Price
25.00
Market Cap Chart
Since May 9, 2006, SHA:600645's market cap has increased from 610.06M to 11.40B, an increase of 1,768.23%. That is a compound annual growth rate of 15.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 11.40B | -0.79% |
| Dec 31, 2025 | 11.49B | 30.57% |
| Dec 31, 2024 | 8.80B | -7.24% |
| Dec 29, 2023 | 9.49B | 19.17% |
| Dec 30, 2022 | 7.96B | -32.61% |
| Dec 31, 2021 | 11.81B | 28.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hualan Biological Vaccine | 12.53B |
| Beijing Hotgen Biotech | 12.47B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 12.15B |
| HitGen | 11.92B |
| Chengdu Easton Biopharmaceuticals | 11.77B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 11.35B |
| Aurisco Pharmaceutical | 10.95B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.76B |